Company / Cash per Share
Vanda Pharmaceuticals Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.46
FY2025
5-year range
$0.95 / $2.42
FY2021-FY2025
Trend
-18.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has declined for 3 consecutive years, from $2.42 in FY2022 to $1.46 in FY2025.
Based on SEC 10-K filings.
1.46 in FY2025 with a 5-year CAGR of +5.0%.
Declined from $2.39 to $1.46 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -15.5%
- 5-Year CAGR
- +5.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- Vanda Pharmaceuticals Inc.'s cash per share has declined for 3 consecutive years.
- In FY2025, cash per share decreased 18.2% year-over-year.
- Peak cash per share was recorded in FY2022.
- Lowest cash per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.46 | -18.2% |
| FY2024 | $1.78 | -25.7% |
| FY2023 | $2.39 | -1.0% |
| FY2022 | $2.42 | +154.5% |
| FY2021 | $0.95 | -16.7% |
| FY2020 | $1.14 | +32.7% |
| FY2019 | $0.86 | -36.7% |
| FY2018 | $1.36 | +77.6% |
| FY2017 | $0.76 | -46.3% |
| FY2016 | $1.42 | -8.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026